HBsAg-话题@MedSci

#HBsAg#

29篇内容 | 1387人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2208673, encodeId=2c3322086e354, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=9d23554e95a' target=_blank style='color:#2F92EE;'>#抗病毒治疗#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【EASL2024速递】通过抗病毒治疗获得HBsAg清除的慢乙肝患者肝癌发生风险或更低, objectType=article, longId=827509, objectId=8f7a82e509e6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240605/1717574376744_5579292.png, objectUrl=/article/show_article.do?id=8f7a82e509e6, replyNumber=0, likeNumber=3, createdTime=2024-06-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8f7a82e509e6, moduleTitle=【EASL2024速递】通过抗病毒治疗获得HBsAg清除的慢乙肝患者肝癌发生风险或更低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f7a82e509e6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2207402, encodeId=a22d220e4025d, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=fcf448e1803' target=_blank style='color:#2F92EE;'>#干扰素α#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【EASL2024速递】聚血糖干扰素α能显著提高核苷停药慢乙肝患者HBsAg清除率, objectType=article, longId=827033, objectId=d5ce82e0333f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240530/1717036023286_5579292.png, objectUrl=/article/show_article.do?id=d5ce82e0333f, replyNumber=0, likeNumber=6, createdTime=2024-05-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d5ce82e0333f, moduleTitle=【EASL2024速递】聚血糖干扰素α能显著提高核苷停药慢乙肝患者HBsAg清除率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d5ce82e0333f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2201791, encodeId=fc782201e9143, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a> <a href='/topic/show?id=859f850513' target=_blank style='color:#2F92EE;'>#HBeAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2023】一对HBV DNA、HBsAg和HBeAg高水平的母女经个体化抗病毒治疗均获长期持久的临床治愈, objectType=article, longId=824075, objectId=96f58240e5c9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/health-insurance-PK235DP.jpg, objectUrl=/article/show_article.do?id=96f58240e5c9, replyNumber=0, likeNumber=16, createdTime=2024-05-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=96f58240e5c9, moduleTitle=【愈见乙肝2023】一对HBV DNA、HBsAg和HBeAg高水平的母女经个体化抗病毒治疗均获长期持久的临床治愈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96f58240e5c9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2201035, encodeId=616a2201035a6, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】吴超教授团队：预测慢乙肝患者HBsAg血清学转换的新指标——基线HBsAb特异性B细胞, objectType=article, longId=823242, objectId=80158232420f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/health-insurance-PK235DP.jpg, objectUrl=/article/show_article.do?id=80158232420f, replyNumber=0, likeNumber=14, createdTime=2024-04-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=80158232420f, moduleTitle=【期刊导读】吴超教授团队：预测慢乙肝患者HBsAg血清学转换的新指标——基线HBsAb特异性B细胞, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=80158232420f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2200404, encodeId=9cba2200404a8, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=5fcb113801f8' target=_blank style='color:#2F92EE;'>#HBsAb#</a>, objectTitle=【期刊导读】HBsAg和HBsAb双阳性的慢乙肝患儿更易实现临床治愈, objectType=article, longId=822489, objectId=19b2822489a0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/black-surgeon-giving-instruction-to-medical-team-TMPFGNZ.jpg, objectUrl=/article/show_article.do?id=19b2822489a0, replyNumber=0, likeNumber=12, createdTime=2024-04-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=19b2822489a0, moduleTitle=【期刊导读】HBsAg和HBsAb双阳性的慢乙肝患儿更易实现临床治愈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19b2822489a0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2198415, encodeId=6d132198415a6, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=a3f3e07054' target=_blank style='color:#2F92EE;'>#ETV#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【临床治愈集结号】免疫耐受期慢乙肝儿童采用聚乙二醇干扰素α联合ETV治疗获HBsAg清除, objectType=article, longId=819902, objectId=03ec819902f2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021554762_4754896.jpeg, objectUrl=/article/show_article.do?id=03ec819902f2, replyNumber=0, likeNumber=17, createdTime=2024-04-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=03ec819902f2, moduleTitle=【临床治愈集结号】免疫耐受期慢乙肝儿童采用聚乙二醇干扰素α联合ETV治疗获HBsAg清除, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03ec819902f2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195713, encodeId=ff4b2195e1313, content=<a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=【期刊导读】首个荟萃分析：聚乙二醇干扰素α治疗慢性HBV感染患者获得HBsAg清除的预测因素, objectType=article, longId=818046, objectId=1507818046bd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-examining-medical-report-PJUYHWX.jpg, objectUrl=/article/show_article.do?id=1507818046bd, replyNumber=0, likeNumber=20, createdTime=2024-03-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=1507818046bd, moduleTitle=【期刊导读】首个荟萃分析：聚乙二醇干扰素α治疗慢性HBV感染患者获得HBsAg清除的预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1507818046bd)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195033, encodeId=6e572195033d1, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=19332343e64' target=_blank style='color:#2F92EE;'>#乙肝疫苗#</a>, objectTitle=【期刊导读】HBsAg清除后接种乙肝疫苗有利于提高HBsAg血清学转换率及抗-HBs水平, objectType=article, longId=817866, objectId=711d81e866ea, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medic-563425_640.jpg, objectUrl=/article/show_article.do?id=711d81e866ea, replyNumber=0, likeNumber=16, createdTime=2024-03-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=711d81e866ea, moduleTitle=【期刊导读】HBsAg清除后接种乙肝疫苗有利于提高HBsAg血清学转换率及抗-HBs水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=711d81e866ea)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2194743, encodeId=8d0c2194e438c, content=<a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=【临床治愈集结号】初治HBeAg阴性慢乙肝患者HBsAg仍阳性时多次停药致病情反复，经多轮PEG IFNα治疗终获临床治愈, objectType=article, longId=817491, objectId=fe6681e491f3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/prescription-form-with-medical-stethoscope-9ZRKVHM.jpg, objectUrl=/article/show_article.do?id=fe6681e491f3, replyNumber=0, likeNumber=27, createdTime=2024-03-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fe6681e491f3, moduleTitle=【临床治愈集结号】初治HBeAg阴性慢乙肝患者HBsAg仍阳性时多次停药致病情反复，经多轮PEG IFNα治疗终获临床治愈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe6681e491f3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2191161, encodeId=a2e3219116104, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=19332343e64' target=_blank style='color:#2F92EE;'>#乙肝疫苗#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=【全球听说】崔富强教授团队：2019年全球5岁以下儿童HBsAg流行率为0.9%, objectType=article, longId=815457, objectId=e98581545e40, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/ccd0b61f0a3894a4bf51f2d065f58b9849794aa5.jpg, objectUrl=/article/show_article.do?id=e98581545e40, replyNumber=0, likeNumber=27, createdTime=2024-03-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e98581545e40, moduleTitle=【全球听说】崔富强教授团队：2019年全球5岁以下儿童HBsAg流行率为0.9%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e98581545e40)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2190737, encodeId=cb792190e37a0, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=412f62143da' target=_blank style='color:#2F92EE;'>#核苷#</a>, objectTitle=【期刊导读】临床治愈率超50%——核苷经治慢乙肝患者和非活动性HBsAg携带状态人群, objectType=article, longId=815453, objectId=e5e181545363, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/prescription-form-with-medical-stethoscope-9ZRKVHM.jpg, objectUrl=/article/show_article.do?id=e5e181545363, replyNumber=0, likeNumber=25, createdTime=2024-03-03, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e5e181545363, moduleTitle=【期刊导读】临床治愈率超50%——核苷经治慢乙肝患者和非活动性HBsAg携带状态人群, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5e181545363)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2182292, encodeId=501021822920c, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=1315194e2b7' target=_blank style='color:#2F92EE;'>#丁型肝炎病毒#</a> <a href='/topic/show?id=4ba78623f2' target=_blank style='color:#2F92EE;'>#HDV#</a>, objectTitle=学术前沿｜Int J Infect Dis：张福杰教授团队阐明丁肝病毒在我国有无HIV-1感染的HBsAg阳性人群中的传播特点, objectType=article, longId=809127, objectId=bcf680912e20, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-at-work-PGMH47J.jpg, objectUrl=/article/show_article.do?id=bcf680912e20, replyNumber=0, likeNumber=29, createdTime=2024-01-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=bcf680912e20, moduleTitle=学术前沿｜Int J Infect Dis：张福杰教授团队阐明丁肝病毒在我国有无HIV-1感染的HBsAg阳性人群中的传播特点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcf680912e20)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1338679, encodeId=cf5a13386e9ab, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=Front Immunol：PEG-IFN a-2a治疗期间HBeAg阳性患者浆细胞样树突状细胞功能分子表达与HBsAg丢失相关, objectType=article, longId=736354, objectId=8d4ce36354d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d4ce36354d3, replyNumber=0, likeNumber=50, createdTime=2022-08-21, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d4ce36354d3, moduleTitle=Front Immunol：PEG-IFN a-2a治疗期间HBeAg阳性患者浆细胞样树突状细胞功能分子表达与HBsAg丢失相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d4ce36354d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338678, encodeId=3e6113386e86a, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=Dig Dis Sci:自发性HBsAg血清学清除与慢性乙型肝炎患者的较低肝纤维化有关, objectType=article, longId=724928, objectId=8a71e249284f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a71e249284f, replyNumber=0, likeNumber=36, createdTime=2022-04-26, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a71e249284f, moduleTitle=Dig Dis Sci:自发性HBsAg血清学清除与慢性乙型肝炎患者的较低肝纤维化有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a71e249284f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338677, encodeId=542813386e740, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=J Hepatology: HBsAg的不同成分可预测HBeAg阳性慢性乙型肝炎患者治疗期间HBsAg的流失情况, objectType=article, longId=206053, objectId=87a720605372, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=87a720605372, replyNumber=0, likeNumber=57, createdTime=2021-01-24, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=87a720605372, moduleTitle=J Hepatology: HBsAg的不同成分可预测HBeAg阳性慢性乙型肝炎患者治疗期间HBsAg的流失情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=87a720605372)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338676, encodeId=7ce813386e63a, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=【华西检验案例】HBsAg转阴＝HBV根除？, objectType=article, longId=198277, objectId=1f231982e78c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f231982e78c, replyNumber=0, likeNumber=50, createdTime=2020-07-30, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f231982e78c, moduleTitle=【华西检验案例】HBsAg转阴＝HBV根除？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f231982e78c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338675, encodeId=2f4f13386e5bf, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=Clinica Chimica Acta：HBcrAg、pg RNA和HBsAg通过抗病毒治疗动态监测HBsAg的血清转化:“HBsAg消失”可能不是抗病毒治疗的良好终点？, objectType=article, longId=190371, objectId=f6061903e196, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6061903e196, replyNumber=0, likeNumber=48, createdTime=2020-03-21, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6061903e196, moduleTitle=Clinica Chimica Acta：HBcrAg、pg RNA和HBsAg通过抗病毒治疗动态监测HBsAg的血清转化:“HBsAg消失”可能不是抗病毒治疗的良好终点？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6061903e196)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338674, encodeId=43c813386e4b3, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=J Hepatology：尽早开始抗病毒治疗可导致婴儿乙型肝炎患者血清HBsAg浓度大量减少, objectType=article, longId=181629, objectId=5c1818162931, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c1818162931, replyNumber=0, likeNumber=40, createdTime=2019-10-21, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c1818162931, moduleTitle=J Hepatology：尽早开始抗病毒治疗可导致婴儿乙型肝炎患者血清HBsAg浓度大量减少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c1818162931)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338673, encodeId=f0dc13386e3c3, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=Digest Dis Sci:如何提高HBsAg清除率、降低晚期肝硬化死亡率..., objectType=article, longId=161282, objectId=7ecf1612824c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7ecf1612824c, replyNumber=0, likeNumber=33, createdTime=2019-02-28, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7ecf1612824c, moduleTitle=Digest Dis Sci:如何提高HBsAg清除率、降低晚期肝硬化死亡率..., moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7ecf1612824c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1338672, encodeId=061e13386e27c, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=Hepatology：HBsAg<100 IU/mL或可作为决定何时停止NAs治疗的可行标志, objectType=article, longId=159331, objectId=593f15933160, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=593f15933160, replyNumber=0, likeNumber=39, createdTime=2019-02-02, rootId=0, userName=12498bb3m90(暂无昵称), userId=7a5c2500147, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=593f15933160, moduleTitle=Hepatology：HBsAg<100 IU/mL或可作为决定何时停止NAs治疗的可行标志, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=593f15933160)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

HBsAg

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#肝癌# #HBsAg# #抗病毒治疗# #慢乙肝#

【EASL2024速递】通过抗病毒治疗获得HBsAg清除的慢乙肝患者肝癌发生风险或更低

2024-06-06发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #干扰素α# #慢乙肝#

【EASL2024速递】聚血糖干扰素α能显著提高核苷停药慢乙肝患者HBsAg清除率

2024-05-30发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #HBV# #HBeAg# #慢乙肝#

【愈见乙肝2023】一对HBV DNA、HBsAg和HBeAg高水平的母女经个体化抗病毒治疗均获长期持久的临床治愈

2024-05-04发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【期刊导读】吴超教授团队：预测慢乙肝患者HBsAg血清学转换的新指标——基线HBsAb特异性B细胞

2024-04-29发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝# #HBsAb#

【期刊导读】HBsAg和HBsAb双阳性的慢乙肝患儿更易实现临床治愈

2024-04-25发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #聚乙二醇干扰素α# #ETV# #慢乙肝#

【临床治愈集结号】免疫耐受期慢乙肝儿童采用聚乙二醇干扰素α联合ETV治疗获HBsAg清除

2024-04-14发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#聚乙二醇干扰素α# #HBV# #HBsAg#

【期刊导读】首个荟萃分析：聚乙二醇干扰素α治疗慢性HBV感染患者获得HBsAg清除的预测因素

2024-03-27发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #乙肝疫苗#

【期刊导读】HBsAg清除后接种乙肝疫苗有利于提高HBsAg血清学转换率及抗-HBs水平

2024-03-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#慢乙肝# #HBsAg# #HBV#

【临床治愈集结号】初治HBeAg阴性慢乙肝患者HBsAg仍阳性时多次停药致病情反复，经多轮PEG IFNα治疗终获临床治愈

2024-03-22发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #乙肝疫苗# #HBV#

【全球听说】崔富强教授团队：2019年全球5岁以下儿童HBsAg流行率为0.9%

2024-03-05发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝# #核苷#

【期刊导读】临床治愈率超50%——核苷经治慢乙肝患者和非活动性HBsAg携带状态人群

2024-03-03发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #丁型肝炎病毒# #HDV#

学术前沿｜Int J Infect Dis：张福杰教授团队阐明丁肝病毒在我国有无HIV-1感染的HBsAg阳性人群中的传播特点

2024-01-17发表于陕西省

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

Front Immunol：PEG-IFN a-2a治疗期间HBeAg阳性患者浆细胞样树突状细胞功能分子表达与HBsAg丢失相关

2022-08-21

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

Dig Dis Sci:自发性HBsAg血清学清除与慢性乙型肝炎患者的较低肝纤维化有关

2022-04-26

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

J Hepatology: HBsAg的不同成分可预测HBeAg阳性慢性乙型肝炎患者治疗期间HBsAg的流失情况

2021-01-24

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

【华西检验案例】HBsAg转阴＝HBV根除？

2020-07-30

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

Clinica Chimica Acta：HBcrAg、pg RNA和HBsAg通过抗病毒治疗动态监测HBsAg的血清转化:“HBsAg消失”可能不是抗病毒治疗的良好终点？

2020-03-21

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

J Hepatology：尽早开始抗病毒治疗可导致婴儿乙型肝炎患者血清HBsAg浓度大量减少

2019-10-21

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

Digest Dis Sci:如何提高HBsAg清除率、降低晚期肝硬化死亡率...

2019-02-28

12498bb3m90(暂无昵称) (审核中...)

前往app查看评论内容

#HBsAg#

Hepatology：HBsAg<100 IU/mL或可作为决定何时停止NAs治疗的可行标志

2019-02-02

科室
- - 订阅+
  - 更多科室
工具
服务